Veracyte Announces New Data Demonstrating Afirma Xpression Atlas Identifies Clinically Relevant Gene Fusions in Thyroid Cancer FNA Samples

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--New data to be presented at ASCO demonstrate Veracyte's Afirma Xpression Atlas test identifies clinically relevant gene fusions in thyroid cancer

Click to view original post